Wilmer Cutler Pickering Hale and Dorr represented Flo Health in the transaction. Flo Health, the #1 downloaded women’s health app worldwide, announced securing more than $200...
Flo Health’s $200 Million Series C Funding Round
Fnality’s £77.7 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented Depository Trust & Clearing Corporation in the transaction. Fnality announced it has secured £77.7M (approximately $97.39 million) in Series B...
Volastra Therapeutics’ $60M Series A Financing
WilmerHale represented Volastra Therapeutics on the deal. Volastra Therapeutics, a clinical stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), closed its $60 million Series...
Houghton Mifflin Harcourt’s $2.8 Billion Merger Agreement with Veritas Capital
Wilmer Cutler Pickering Hale and Dorr advised Houghton Mifflin Harcourt on the deal while Milbank represented Veritas Capital. Houghton Mifflin Harcourt Company (HMH), a learning technology...
Crescera Capital Acquisition’s $201 Million Initial Public Offering
Davis Polk advised Crescera Capital Acquisition Corp. on the deal while Wilmer Cutler Pickering Hale and Dorr represented the underwriter. Crescera Capital Acquisition Corp. executed its...